Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Lymphoma
>>
Roche
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
4
8
12
16
20
24
28
32
36
40
Tecentriq
(atezolizumab) / Roche
Cytovene
(ganciclovir) / Roche
Zelboraf
(vemurafenib) / Roche
Erivedge
(vismodegib) / Roche
Aplidin
(plitidepsin) / PharmaMar, Roche
Cotellic
(cobimetinib) / Exelixis, Roche
Herceptin
(trastuzumab) / Roche
RG4733
/ Roche
Rozlytrek
(entrectinib) / Roche
taselisib
(GDC-0032) / Roche
PRO131921
/ Roche
Pegasys
(pegylated interferon α -2a) / Roche
Perjeta
(pertuzumab) / Roche
SPC2996
/ Roche
Vesanoid
(tretinoin) / Roche
drozitumab
(RG7425) / Roche
idasanutlin
(RG7388) / Roche
pinatuzumab vedotin
(RG7593) / Roche
Ebglyss
(lebrikizumab) / Eli Lilly
Ocrevus
(ocrelizumab) / Roche, Biogen
Raptiva
(efalizumab) / Roche, EMD Serono, Xoma
dulanermin
(AMG 951) / Amgen, Roche
